search
Back to results

Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia (ATS2B)

Primary Purpose

Amblyopia

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Eye patch
Sponsored by
Jaeb Center for Health Research
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Amblyopia

Eligibility Criteria

3 Years - 7 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Patients must be less than 7 years of age with the original cause of amblyopia as strabismus or anisometropia. Visual Acuity in the amblyopic eye must be between 20/40 and 20/80. Visual acuity in the sound eye of 20/40 or better. There must be at least 3 lines of acuity difference between the two eyes. Exclusion Criteria: Patching treatment (other than spectacles) within six months prior to enrollment and other amblyopia treatment of any type used within one month prior to enrollment.

Sites / Locations

  • Wilmer Eye Institute

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

2hrs daily patching

6hrs daily patching

Arm Description

2 hours patching per day to cover the sound eye

6 hours per day patching to cover the sound eye

Outcomes

Primary Outcome Measures

Visual acuity improvement

Secondary Outcome Measures

Full Information

First Posted
October 21, 2004
Last Updated
September 8, 2010
Sponsor
Jaeb Center for Health Research
Collaborators
National Eye Institute (NEI)
search

1. Study Identification

Unique Protocol Identification Number
NCT00094679
Brief Title
Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia
Acronym
ATS2B
Official Title
A Randomized Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia
Study Type
Interventional

2. Study Status

Record Verification Date
September 2010
Overall Recruitment Status
Completed
Study Start Date
May 2001 (undefined)
Primary Completion Date
July 2002 (Actual)
Study Completion Date
September 2002 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Jaeb Center for Health Research
Collaborators
National Eye Institute (NEI)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The goals of this study are: To determine whether the visual acuity improvement obtained with part-time (6 hours) patching is equivalent to the visual acuity improvement obtained with minimal patching (2 hours) for moderate amblyopia. To develop more precise estimates than currently available for the visual acuity improvement that occurs during treatment of amblyopia with patching. To identify factors that may be associated with successful treatment of amblyopia with patching.
Detailed Description
Amblyopia is the most common cause of monocular visual impairment in both children and young and middle-aged adults. Patching has been the mainstay of amblyopia therapy. It is generally held that the response to treatment is best when it is instituted at an early age, particularly by age two or three, and is poor when attempted after eight years of age. For moderate amblyopia, patching is the most commonly prescribed treatment although other modalities such as atropine penalization are also prescribed. There is no specific patching regimen that is widely accepted for treatment of moderate amblyopia and limited or no data available to favor the use of one specific regimen; both minimal occlusion (e.g., 2 hours per day) and six or more hours per day of patching are prescribed in clinical practice. The study is a randomized trial comparing daily patching regimes for children with moderate amblyopia. It will consist of about 160 children. Patients in the moderate (20/40-20/80) group will patch part-time (6 hours) or minimal time (2 hours) of each day for the 4-month study period. There are at least two follow up visits during the 4-month period. Visual acuity is the major study outcome. It is assessed at the 4-month exam.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Amblyopia

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
189 (Actual)

8. Arms, Groups, and Interventions

Arm Title
2hrs daily patching
Arm Type
Active Comparator
Arm Description
2 hours patching per day to cover the sound eye
Arm Title
6hrs daily patching
Arm Type
Active Comparator
Arm Description
6 hours per day patching to cover the sound eye
Intervention Type
Device
Intervention Name(s)
Eye patch
Other Intervention Name(s)
Coverlet, Opticlude
Intervention Description
adhesive patch to cover the sound eye
Primary Outcome Measure Information:
Title
Visual acuity improvement
Time Frame
17 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
3 Years
Maximum Age & Unit of Time
7 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients must be less than 7 years of age with the original cause of amblyopia as strabismus or anisometropia. Visual Acuity in the amblyopic eye must be between 20/40 and 20/80. Visual acuity in the sound eye of 20/40 or better. There must be at least 3 lines of acuity difference between the two eyes. Exclusion Criteria: Patching treatment (other than spectacles) within six months prior to enrollment and other amblyopia treatment of any type used within one month prior to enrollment.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael X Repka, M.D.
Organizational Affiliation
Wilmer Eye Institute
Official's Role
Study Chair
Facility Information:
Facility Name
Wilmer Eye Institute
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21287-9028
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
12742836
Citation
Repka MX, Beck RW, Holmes JM, Birch EE, Chandler DL, Cotter SA, Hertle RW, Kraker RT, Moke PS, Quinn GE, Scheiman MM; Pediatric Eye Disease Investigator Group. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol. 2003 May;121(5):603-11. doi: 10.1001/archopht.121.5.603.
Results Reference
background
PubMed Identifier
20451898
Citation
Repka M, Simons K, Kraker R; Pediatric Eye Disease Investigator Group. Laterality of amblyopia. Am J Ophthalmol. 2010 Aug;150(2):270-4. doi: 10.1016/j.ajo.2010.01.040. Epub 2010 May 8.
Results Reference
derived

Learn more about this trial

Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia

We'll reach out to this number within 24 hrs